• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[氦氖激光治疗缺血性心脏病患者时病情加重现象的临床病理化学依据]

[Clinico-pathochemical substantiation of the exacerbation phenomenon in patients with ischemic heart disease during treatment with the helium-neon laser].

作者信息

Korochkin I M, Kartelishev A V, Leshakov S Iu, Kapustina G M, Vernekina N S

出版信息

Kardiologiia. 1988 Aug;28(8):72-5.

PMID:3199659
Abstract

Some pathochemical mechanisms of coronary disease aggravation in the course of laser therapy were assessed by means of the measurement of erythrocyte membrane lipids and phospholipids as well as plasma alpha-tocopherol and diene conjugate levels. The aggravation was associated with an activation of metabolic processes aiming to produce regeneration of membrane structures. The regeneration takes place in the presence of chronic deficiency of total phospholipids and inadequate antioxidant protection of biomembranes, therefore complete stabilization and normalization of their composition and activity is impossible.

摘要

通过测量红细胞膜脂质和磷脂以及血浆α-生育酚和二烯结合物水平,评估了激光治疗过程中冠心病加重的一些病理化学机制。病情加重与旨在产生膜结构再生的代谢过程激活有关。再生发生在总磷脂长期缺乏和生物膜抗氧化保护不足的情况下,因此其组成和活性不可能完全稳定和正常化。

相似文献

1
[Clinico-pathochemical substantiation of the exacerbation phenomenon in patients with ischemic heart disease during treatment with the helium-neon laser].[氦氖激光治疗缺血性心脏病患者时病情加重现象的临床病理化学依据]
Kardiologiia. 1988 Aug;28(8):72-5.
2
[Clinico-biochemical parallels against a background of traditional treatment and laser therapy of patients with ischemic heart disease].[缺血性心脏病患者传统治疗和激光治疗背景下的临床生化指标对比]
Ter Arkh. 1988;60(12):40-4.
3
[Plasma and platelet lipids in patients with newly diagnosed angina and chronic heart disease].[新诊断心绞痛和慢性心脏病患者的血浆及血小板脂质]
Vopr Med Khim. 1990 Jul-Aug;36(4):24-8.
4
[The mechanisms of the development of secondary exacerbation during laser therapy in patients with ischemic heart disease and the possible ways to prevent it].[缺血性心脏病患者激光治疗期间继发性病情加重的发生机制及预防的可能方法]
Vopr Kurortol Fizioter Lech Fiz Kult. 1999 Sep-Oct(5):3-4.
5
[The laser therapy of patients with hypertension in combination with coronary insufficiency].[高血压合并冠状动脉供血不足患者的激光治疗]
Vopr Kurortol Fizioter Lech Fiz Kult. 1996 Mar-Apr(2):3-5.
6
[Mechanism of the therapeutic effect of the helium-neon laser in ischemic heart disease].[氦氖激光治疗缺血性心脏病的疗效机制]
Klin Med (Mosk). 1985 Oct;63(10):102-5.
7
[The effect of transvenous laser therapy on lipid peroxidation function in patients with ischemic heart disease].[经静脉激光治疗对缺血性心脏病患者脂质过氧化功能的影响]
Kardiologiia. 1992 Jul;32(7-8):43-5.
8
[Lipid peroxidation as an indicator of the effectiveness of treating patients with chronic ischemic heart disease using a helium-neon laser].[脂质过氧化作为使用氦氖激光治疗慢性缺血性心脏病患者疗效的指标]
Klin Med (Mosk). 1989 Jul;67(7):37-9.
9
[Treatment of stenocardia with the helium-neon laser].[氦氖激光治疗心绞痛]
Med Sestra. 1989 Mar;48(3):22-5.
10
[Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities].普罗布考对脂质代谢及缺血性心脏病和下肢血管闭塞性动脉硬化临床病程的影响
Kardiologiia. 1984 Jun;24(6):76-9.